Goldman Sachs
HLTH

Goldman Sachs’s Cue Health Inc. Common Stock HLTH Stock Holding History

Goldman Sachs’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,900
Closed -$83K – 6802
2022
Q1 		$83K Buy
+12,900
New +$117K ﹤0.01% 6163

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OPTFSNA
Old Point Trust & Financial Services N A Newport News, Virginia $329M AUM 22.88% 1-Year Est. Return
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Goldman Sachs's HLTH Position: Q2 2024 in Review

Goldman Sachs sold out of Cue Health Inc. Common Stock (HLTH) in Q2 2024, closing a stake of 2,850,551 shares — an estimated $538K sold.

Goldman Sachs first reported a position in HLTH in Q3 2021 and held it in 11 quarters. The position peaked at $13.1M in Q3 2021. 9 funds tracked by Wall St. Rank hold HLTH as of Q2 2024.

  • Goldman Sachs reported no remaining Cue Health Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 2,850,551 Cue Health Inc. Common Stock shares in Q2 2024, an estimated $538K.
  • Goldman Sachs first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • Goldman Sachs's Cue Health Inc. Common Stock position peaked at $13.1M in Q3 2021.
  • 9 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.